News
Biosimilar Insulin Significantly Lowers HbA1c in Mali, But Access Remains a Challenge
Our new study published in Diabetic Medicine has demonstrated significant improvements in glycaemic control among children and young adults living with Type 1 Diabetes (T1D) in Mali following the introduction of biosimilar glargine, a long-acting analogue insulin.
Public health is challenged by lobbies : “Decisions should not be imposed by economical interests, but by those of consumers, patients.”
Should public health decisions be guided by the interests of consumers and patients or by the economic imperatives of companies? In a joint interview with Le Monde, Serge Hercberg, a nutritionist and initiator of the Nutri-Score, and Stéphane Besançon, director of the NGO Santé Diabète and advocate for insulin access, denounce the pressures exerted by…
Public health vs. lobbies: a necessary fight for consumers and patients
Les décisions en matière de santé publique doivent-elles être guidées par l’intérêt des consommateurs et des patients ou par les impératifs économiques des entreprises ? Dans un entretien croisé avec Le Monde, Serge Hercberg, nutritionniste et initiateur du Nutri-Score, et Stéphane Besançon, directeur de l’ONG Santé Diabète et défenseur de l’accès à l’insuline, dénoncent les…
Cyclone Chido in Mayotte: the State must guarantee continuity of care for people living with diabetes
Grenoble, January 2, 2025 - The devastating passage of cyclone Chido on December 14, 2024 has plunged the Mayotte archipelago into a humanitarian emergency. A French overseas department in the Indian Ocean, Mayotte is home to more than 320,000 inhabitants, 10% of whom live with diabetes, a rate twice that of mainland France.
À l’approche de la Journée Mondiale du Diabète, les entreprises pharmaceutiques telles que Eli Lilly, Novo Nordisk et Sanofi doivent rendre les stylos à insuline disponibles à 1 dollar par stylo.
L’ONG Santé Diabète se mobilise aux côtés de Médecins Sans Frontières Access Campaign, T1International et Treatment Action Campaign le 14 novembre 2024 lors d’une manifestation devant le siège de Novo Nordisk à Sandton, en Afrique du Sud, pour demander à l’industriel de rendre les stylos à insuline disponibles à 1 dollar par stylo. À cette…
Making Nutri-Score Mandatory is a Public Health Emergency
Suite à la tribune publiée par Mathilde Touvier, Cynthia Fleury, Serge Hercberg et Stéphane Besançon dans le journal Le Monde le 24 octobre 2024, un collectif de 1 142 scientifiques et professionnels de santé appelle le Premier Ministre à rendre le Nutri-Score obligatoire en France. Le logo nutritionnel Nutri-Score représente un véritable outil de santé…
Santé Diabète releases its 2023 annual report
Our annual report provides an overview of Santé Diabète's activities and achievements. The year 2023 marked a transition for Santé Diabète, despite a deteriorated institutional, political and security context in the Sahel. The organization succeeded in ensuring the continuity of its interventions with the launch of the second phase of our program...
Biannual bulletin july-december 2023 of Santé Diabète
The second half of 2023 was devoted to the launch of our new 3-year program. Read our bulletin to find out more.
BIANNUAL BULLETIN JANUARY-JUNE 2023 OF SANTÉ DIABÈTE
What activities did Santé Diabète carry out in the first half of 2023? Read our biannual bulletin to find out.
SANTÉ DIABETE’s 2022 ANNUAL REPORT
To find all the results of the activities carried out in 2022, you can read and download our annual report from this link : Santé Diabète’s 2022 Annual report. MESSAGE FROM THE CHAIR OF THE BOARD OF SANTE DIABETES, M. DAVID HACQUIN, TO CONCLUDE THIS YEAR 2022 For nearly 20 years...
English (UK) 
Français